The minimally invasive spine surgery market is expected to reach $4.16 billion globally, according to a market research report from DataM intelligence.
Five notes:
1. The global MISS market reached $2.67 billion in 2022 and is expected to grow to $4.16 billion, or 5.8% CAGR, by 2031.
2. Market growth is driven by increased prevalence for spinal disorders, aging populations and demand for faster surgical recovery.
3. North America leads the global market share with 35%.
4. The U.S. MISS market is expected to reach $1.2 billion by 2031.
5. Key companies in the MISS market include Zimmer Biomet, DePuy Synthes, Stryker and Medtronic.
